2014-2023年中国幽门螺杆菌感染率:系统回顾与荟萃分析。

IF 4.3 3区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY World Journal of Gastroenterology Pub Date : 2024-11-21 DOI:10.3748/wjg.v30.i43.4636
Lu Xie, Guang-Wei Liu, Ya-Nan Liu, Peng-Yu Li, Xin-Ning Hu, Xin-Yi He, Rui-Bo Huan, Tai-Long Zhao, Hui-Jun Guo
{"title":"2014-2023年中国幽门螺杆菌感染率:系统回顾与荟萃分析。","authors":"Lu Xie, Guang-Wei Liu, Ya-Nan Liu, Peng-Yu Li, Xin-Ning Hu, Xin-Yi He, Rui-Bo Huan, Tai-Long Zhao, Hui-Jun Guo","doi":"10.3748/wjg.v30.i43.4636","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong><i>Helicobacter pylori (H. pylori)</i> stands as the predominant infectious agent linked to the onset of gastritis, peptic ulcer diseases, and gastric cancer (GC). Identified as the exclusive bacterial factor associated with the onset of GC, it is classified as a group 1 carcinogen by the World Health Organization. The elimination of <i>H. pylori</i> plays a crucial role in the primary prevention of GC. While the prevalence has declined in recent decades, <i>H. pylori</i> infection is still highly prevalent in China, accounting for a significant part of the disease burden of GC. Therefore, updated prevalence information for <i>H. pylori</i> infection, especially regional and demographic variations in China, is an important basis for the design of targeted strategies that will be effective for the prevention of GC and application of policies for <i>H. pylori</i> control.</p><p><strong>Aim: </strong>To methodically evaluate the occurrence of <i>H. pylori</i> infection throughout China and establish a reference point for subsequent investigations.</p><p><strong>Methods: </strong>A systematic review and meta-analysis was conducted following established guidelines, as detailed in our methodology section.</p><p><strong>Results: </strong>Our review synthesized data from 152 studies, covering a sample of 763827 individuals, 314423 of whom were infected with <i>H. pylori</i>. We evaluated infection rates in mainland China and the combined prevalence of <i>H. pylori</i> was 42.8% (95%CI: 40.7-44.9). Subgroup analysis indicated the highest prevalence in Northwest China at 51.3% (95%CI: 45.6-56.9), and in Qinghai Province, the prevalence reached 60.2% (95%CI: 46.5-73.9). The urea breath test, which recorded the highest infection rate, showed a prevalence of 43.7% (95%CI: 41.4-46.0). No notable differences in infection rates were observed between genders. Notably, the prevalence among the elderly was significantly higher at 44.5% (95%CI: 41.9-47.1), compared to children, who showed a prevalence of 27.5% (95%CI: 19.58-34.7).</p><p><strong>Conclusion: </strong>Between 2014 and 2023, the prevalence of <i>H. pylori</i> infection in China decreased to 42.8%, down from the previous decade. However, the infection rates vary considerably across different geographical areas, among various populations, and by detection methods employed.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"30 43","pages":"4636-4656"},"PeriodicalIF":4.3000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572641/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prevalence of <i>Helicobacter pylori</i> infection in China from 2014-2023: A systematic review and meta-analysis.\",\"authors\":\"Lu Xie, Guang-Wei Liu, Ya-Nan Liu, Peng-Yu Li, Xin-Ning Hu, Xin-Yi He, Rui-Bo Huan, Tai-Long Zhao, Hui-Jun Guo\",\"doi\":\"10.3748/wjg.v30.i43.4636\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong><i>Helicobacter pylori (H. pylori)</i> stands as the predominant infectious agent linked to the onset of gastritis, peptic ulcer diseases, and gastric cancer (GC). Identified as the exclusive bacterial factor associated with the onset of GC, it is classified as a group 1 carcinogen by the World Health Organization. The elimination of <i>H. pylori</i> plays a crucial role in the primary prevention of GC. While the prevalence has declined in recent decades, <i>H. pylori</i> infection is still highly prevalent in China, accounting for a significant part of the disease burden of GC. Therefore, updated prevalence information for <i>H. pylori</i> infection, especially regional and demographic variations in China, is an important basis for the design of targeted strategies that will be effective for the prevention of GC and application of policies for <i>H. pylori</i> control.</p><p><strong>Aim: </strong>To methodically evaluate the occurrence of <i>H. pylori</i> infection throughout China and establish a reference point for subsequent investigations.</p><p><strong>Methods: </strong>A systematic review and meta-analysis was conducted following established guidelines, as detailed in our methodology section.</p><p><strong>Results: </strong>Our review synthesized data from 152 studies, covering a sample of 763827 individuals, 314423 of whom were infected with <i>H. pylori</i>. We evaluated infection rates in mainland China and the combined prevalence of <i>H. pylori</i> was 42.8% (95%CI: 40.7-44.9). Subgroup analysis indicated the highest prevalence in Northwest China at 51.3% (95%CI: 45.6-56.9), and in Qinghai Province, the prevalence reached 60.2% (95%CI: 46.5-73.9). The urea breath test, which recorded the highest infection rate, showed a prevalence of 43.7% (95%CI: 41.4-46.0). No notable differences in infection rates were observed between genders. Notably, the prevalence among the elderly was significantly higher at 44.5% (95%CI: 41.9-47.1), compared to children, who showed a prevalence of 27.5% (95%CI: 19.58-34.7).</p><p><strong>Conclusion: </strong>Between 2014 and 2023, the prevalence of <i>H. pylori</i> infection in China decreased to 42.8%, down from the previous decade. However, the infection rates vary considerably across different geographical areas, among various populations, and by detection methods employed.</p>\",\"PeriodicalId\":23778,\"journal\":{\"name\":\"World Journal of Gastroenterology\",\"volume\":\"30 43\",\"pages\":\"4636-4656\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-11-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572641/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Gastroenterology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3748/wjg.v30.i43.4636\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3748/wjg.v30.i43.4636","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:幽门螺杆菌(H. pylori)是与胃炎、消化性溃疡病和胃癌(GC)发病有关的主要感染病原体。幽门螺杆菌被确定为与胃癌发病有关的唯一细菌因素,并被世界卫生组织列为 1 类致癌物。消除幽门螺杆菌在胃癌的一级预防中起着至关重要的作用。虽然近几十年来幽门螺杆菌的感染率有所下降,但在中国仍然非常普遍,在胃癌的疾病负担中占了很大一部分。因此,幽门螺杆菌感染的最新流行情况,尤其是中国的地区和人口变化情况,是设计有效预防 GC 的针对性策略和实施幽门螺杆菌控制政策的重要依据:方法:按照既定指南进行系统综述和荟萃分析,详见我们的方法部分:我们的综述综合了 152 项研究的数据,涉及样本 763827 人,其中 314423 人感染了幽门螺杆菌。我们评估了中国大陆的感染率,幽门螺杆菌的综合感染率为 42.8%(95%CI:40.7-44.9)。分组分析表明,西北地区的感染率最高,为 51.3%(95%CI:45.6-56.9),青海省的感染率达到 60.2%(95%CI:46.5-73.9)。尿素呼气试验的感染率最高,为 43.7%(95%CI:41.4-46.0)。不同性别之间的感染率没有明显差异。值得注意的是,老年人的感染率为 44.5%(95%CI:41.9-47.1),明显高于儿童,后者的感染率为 27.5%(95%CI:19.58-34.7):结论:2014 年至 2023 年期间,中国幽门螺杆菌感染率下降至 42.8%,低于前十年的水平。然而,不同地理区域、不同人群以及不同检测方法的感染率差异很大。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Prevalence of Helicobacter pylori infection in China from 2014-2023: A systematic review and meta-analysis.

Background: Helicobacter pylori (H. pylori) stands as the predominant infectious agent linked to the onset of gastritis, peptic ulcer diseases, and gastric cancer (GC). Identified as the exclusive bacterial factor associated with the onset of GC, it is classified as a group 1 carcinogen by the World Health Organization. The elimination of H. pylori plays a crucial role in the primary prevention of GC. While the prevalence has declined in recent decades, H. pylori infection is still highly prevalent in China, accounting for a significant part of the disease burden of GC. Therefore, updated prevalence information for H. pylori infection, especially regional and demographic variations in China, is an important basis for the design of targeted strategies that will be effective for the prevention of GC and application of policies for H. pylori control.

Aim: To methodically evaluate the occurrence of H. pylori infection throughout China and establish a reference point for subsequent investigations.

Methods: A systematic review and meta-analysis was conducted following established guidelines, as detailed in our methodology section.

Results: Our review synthesized data from 152 studies, covering a sample of 763827 individuals, 314423 of whom were infected with H. pylori. We evaluated infection rates in mainland China and the combined prevalence of H. pylori was 42.8% (95%CI: 40.7-44.9). Subgroup analysis indicated the highest prevalence in Northwest China at 51.3% (95%CI: 45.6-56.9), and in Qinghai Province, the prevalence reached 60.2% (95%CI: 46.5-73.9). The urea breath test, which recorded the highest infection rate, showed a prevalence of 43.7% (95%CI: 41.4-46.0). No notable differences in infection rates were observed between genders. Notably, the prevalence among the elderly was significantly higher at 44.5% (95%CI: 41.9-47.1), compared to children, who showed a prevalence of 27.5% (95%CI: 19.58-34.7).

Conclusion: Between 2014 and 2023, the prevalence of H. pylori infection in China decreased to 42.8%, down from the previous decade. However, the infection rates vary considerably across different geographical areas, among various populations, and by detection methods employed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
World Journal of Gastroenterology
World Journal of Gastroenterology 医学-胃肠肝病学
CiteScore
7.80
自引率
4.70%
发文量
464
审稿时长
2.4 months
期刊介绍: The primary aims of the WJG are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in gastroenterology and hepatology.
期刊最新文献
Advances in artificial intelligence for predicting complication risks post-laparoscopic radical gastrectomy for gastric cancer: A significant leap forward. Comprehensive approach to esophageal variceal bleeding: From prevention to treatment. Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function. Improving early diagnosis of multiple endocrine neoplasia type 1 by assessing the gastrointestinal symptoms, hypercalcemia, and elevated serum gastrin. Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1